ISSN: 2149-2247 | E-ISSN: 2149-2549

Quick Search




Neoadjuvant Doxorubicin and Docetaxel in Breast Cancer Patients Applied Neutropenic Enterocolitis [Erciyes Med J]
Erciyes Med J. Ahead of Print: EMJ-39114 | DOI: 10.14744/etd.2019.39114

Neoadjuvant Doxorubicin and Docetaxel in Breast Cancer Patients Applied Neutropenic Enterocolitis

Hatice Sarıkaya Aslan, Mevlüde Inanç
Department of Internal Medicine, Kayseri Training and Research Hospital, Kayseri, Turkey

Neutropenic enterocolitis is an acute complication of neutropenia induced by chemotherapy, characterized by inflammatory processes involving colon and cecum that can lead to necrosis, hemorrhage, perforation and septicaemia. Usually this syndrome develops after cytotoxic drug use and fever and abdominal pain are the main symptoms.We present a case of typhlitis in a 38 year old female patient with breast cancer who received Doxorubicin and Docetaxel.

Keywords: Neutropenic enterocolitis, Neoadjuvant therapy, Doxorubicin andDocetaksel.



Corresponding Author: Hatice Sarıkaya Aslan, Türkiye
LookUs & Online Makale